Actos Bladder Cancer
The U.S. Food and Drug Administration (FDA) has informed the public that use of the diabetes medication Actos (pioglitazone) for much more than one year might be linked with an improved threat of bladder cancer. Info about this danger will be added to the Warnings and Precautions section of the label for pioglitazone-containing medicines, such [...]